ATM and ataxia telangiectasia. Second in molecular medicine review series

EMBO Reports

Volumn 5, Issue 8, 2004, Pages 772-776

  McKinnon, Peter J ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Ataxia telangiectasia; ATM; DNA damage; Neurodegeneration

Indexed keywords

ATM PROTEIN; DOUBLE STRANDED DNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE;

ATAXIA TELANGIECTASIA; CANCER PREVENTION; DEGENERATIVE DISEASE; DNA DAMAGE; DNA STRAND BREAKAGE; ENZYME SUBSTRATE; GENE MUTATION; GENETIC ANALYSIS; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; RARE DISEASE; RETROSPECTIVE STUDY; REVIEW; SIGNAL TRANSDUCTION;

ATAXIA TELANGIECTASIA; CELL CYCLE; CELL CYCLE PROTEINS; DNA DAMAGE; DNA-BINDING PROTEINS; HUMANS; NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

NEXUS;

EID: 4444339751     PISSN: 1469221X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.embor.7400210     Document Type: Review

References (59)

1. Abner CW, McKinnon PJ (2004) The DNA double-strand break response in the nervous system. DNA Repair (Amst) (in press)
2. Angele S et al (2003) ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity. Cancer Res 63: 8717-8725
3. Baker SJ, McKinnon PJ (2004) Tumour-suppressor function in the nervous system. Nat Rev Cancer 4: 184-196
4. Bakkenist CJ, Kastan MB (2003) DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421: 499-506
5. Barlow C, Liyanage M, Moens PB, Deng CX, Ried T, Wynshaw-Boris A (1997) Partial rescue ofthe prophase I defects of Atm-deficient mice by p53 and p21 null alleles. Nat Genet 17: 462-466
6. Barlow C, Dennery PA, Shigenaga MK, Smith MA, Morrow JD, Roberts LJ II, Wynshaw-Boris A, Levine RL (1999) Loss of the ataxia-telangiectasia gene product causes oxidative damage in target organs. Proc Natl Acad Sci USA 96: 9915-9919
7. Barnes DE, Stamp G, Rosewell I, Denzel A, Lindahl T (1998) Targeted disruption of the gene encoding DNA ligase IV leads to lethality in embryonic mice. Curr Biol 8: 1395-1398
8. Borges HL, Chao C, Xu Y, Linden R, Wang JY (2004) Radiation-induced apoptosis in developing mouse retina exhibits dose-dependent requirement for ATM phosphorylation of p53. Cell Death Differ 11: 494-502
9. Boultwood J (2001) Ataxia telangiectasia gene mutations in leukaemia and lymphoma. J Clin Pathol 54: 512-516
10. Caldecott KW (2003) DNA single-strand break repair and spinocerebellar ataxia. Cell 112: 7-10
11. Carney JP, Maser RS, Olivares H, Davis EM, Le Beau M, Yates JR III, Hays L, Morgan WF, Petrini JH (1998) The hMre11/hRad50 protein complex and Nijmegen breakage syndrome: linkage of double-strand break repair to the cellular DNA damage response. Cell 93: 477-486
12. Carson CT, Schwartz RA, Stracker TH, Lilley CE, Lee DV, Weitzman MD (2003) The Mre11 complex is required for ATM activation and the G(2)/M checkpoint. EMBO J 22: 6610-6620
13. Crawford TO (1998) Ataxia telangiectasia. Semin Pediatr Neurol 5: 287-294
14. D'Amours D, Jackson SP (2002) The Mre11 complex: at the crossroads of DNA repair and checkpoint signalling. Nat Rev Mol Cell Biol 3: 317-327
15. Date H et al(2001) Early-onset ataxia with ocular motor apraxia and hypoalbuminemia is caused by mutations in a new HIT superfamily gene. Nat Genet 29: 184-188
16. Farina L, Uggetti C, Ottolini A, Martelli A, Bergamaschi R, Sibilla L, Zappoli F, Egitto MG, Lanzi G (1994) Ataxia-telangiectasia: MR and CT findings. J Comput Assist Tomogr 18: 724-727
17. FitzGerald MG, Bean JM, Hegde SR, Unsal H, MacDonald DJ, Harkin DP, Finkelstein DM, Isselbacher KJ, Haber DA (1997) Heterozygous ATM mutations do not contribute to early onset of breast cancer. Nat Genet 15: 307-310
18. Gao Y et al (1998) A critical role for DNA end-joining proteins in both lymphogenesis and neurogenesis. Cell 95: 891-902
19. Gatti RA et al (2001) The pathogenesis of ataxia-telangiectasia. Learning from a Rosetta stone. Clin Rev Allergy Immunol 20: 87-108
20. Gueven N et al (2004) Aprataxin, a novel protein that protects against genotoxic stress. Hum Mol Genet 13: 1081-1093
21. Gumy-Pause F, Wacker P, Sappino AP (2004) ATM gene and lymphoid malignancies. Leukemia 18: 238-242
22. Herzog KH, Chong MJ, Kapsetaki M, Morgan JI, McKinnon PJ (1998) Requirement for Atm in ionizing radiation-induced cell death in the developing central nervous system. Science 280: 1089-1091
23. Hoeijmakers JH (2001) Genome maintenance mechanisms for preventing cancer. Nature 411: 366-374
24. Kamsler A, Daily D, Hochman A, Stern N, Shiloh Y, Rotman G, Barzilai A (2001) Increased oxidative stress in ataxia telangiectasia evidenced by alterations in redox state of brains from Atm-deficient mice. Cancer Res 61: 1849-1854
25. Kastan MB, Lim DS (2000) The many substrates and functions of ATM. Nat Rev Mol Cell Biol 1: 179-186
26. Kitagawa R, Bakkenist CJ, McKinnon PJ, Kastan MB (2004) Phosphorylation of SMC1 is a critical downstream event in the ATM-NBS1-BRCA1 pathway. Genes Dev 18: 1423-1438
27. Lakin ND, Weber P, Stankovic T, Rottinghaus ST, Taylor AM, Jackson SP (1996) Analysis of the ATM protein in wild-type and ataxia telangiectasia cells. Oncogene 13: 2707-2716
28. Lee JH, Paull TT (2004) Direct activation of the ATM protein kinase by the Mre11/Rad50/Nbs1 complex. Science 304: 93-96
29. Lee Y, Barnes DE, Lindahl T, McKinnon PJ (2000) Defective neurogenesis resulting from DNA ligase IV deficiency requires Atm. Genes Dev 14: 2576-2580
30. Lee Y, Chong MJ, McKinnon PJ (2001) Ataxia telangiectasia mutated-dependent apoptosis after genotoxic stress in the developing nervous system is determined by cellular differentiation status. J Neurosci 21: 6687-6693
31. Lefton-Greif MA, Crawford TO, Winkelstein JA, Loughlin GM, Koerner CB, Zahurak M, Lederman HM (2000) Oropharyngeal dysphagia and aspiration in patients with ataxia-telangiectasia. J Pediatr 136: 225-231
32. Lewis RF, Lederman HM, Crawford TO (1999) Ocular motor abnormalities in ataxia telangiectasia. Ann Neurol 46: 287-295
33. Liao MJ, Van Dyke T (1999) Critical role for Atm in suppressing V(D)J recombination-driven thymic lymphoma. Genes Dev 13: 1246-1250
34. Moreira MC et al (2001) The gene mutated in ataxia-ocular apraxia 1 encodes the new HIT/Zn-finger protein aprataxin. Nat Genet 29: 189-193
35. Motoyama N, Naka K (2004) DNA damage tumor suppressor genes and genomic instability. Curr Opin Genet Dev 14: 11-16
36. Nowak R (1995) Discovery of AT gene sparks biomedical research bonanza. Science 268: 1700-1701
37. Nowak-Wegrzyn A, Crawford TO, Winkelstein JA, Carson KA, Lederman HM (2004) Immunodeficiency and infections in ataxia-telangiectasia. J Pediatr 144: 505-511
38. Perkins EJ, Nair A, Cowley DO, Van Dyke T, Chang Y, Ramsden DA (2002) Sensing of intermediates in V(D)J recombination by ATM. Genes Dev 16: 159-164
39. Perlman S, Becker-Catania S, Gatti RA (2003) Ataxia-telangiectasia: diagnosis and treatment. Semin Pediatr Neurol 10: 173-182
40. Petrini JH, Stracker TH (2003) The cellular response to DNA double-strand breaks: defining the sensors and mediators. Trends Cell Biol 13: 458-462
41. Quick KL, Dugan LL (2001) Superoxide stress identifies neurons at risk in a model of ataxia-telangiectasia. Ann Neurol 49: 627-635
42. Rolig RL, McKinnon PJ (2000) Linking DNA damage and neurodegeneration. Trends Neurosci 23: 417-424
43. Sandoval N et al (1999) Characterization of ATM gene mutations in 66 ataxia telangiectasia families. Hum Mol Genet 8: 69-79
44. Savitsky K et al (1995) A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268: 1749-1753
45. Sedelnikova OA, Pilch DR, Redon C, Bonner WM (2003) Histone H2AX in DNA damage and repair. Cancer Biol Ther 2: 233-235
46. Sedgwick RP, Boder E (1991) Ataxia-telangiectasia. In Handbook of Clinical Neurology Vol 60 (eds Vinken P, Bruyn G, Klawans H) 347-423. New York, USA: Elsevier.
47. Sekiguchi J et al (2001) Genetic interactions between ATM and the nonhomologous end-joining factors in genomic stability and development. Proc Natl Acad Sci USA 98: 3243-3248
48. Shiloh Y (1997) Ataxia-telangiectasia and the Nijmegen breakage syndrome: related disorders but genes apart. Annu Rev Genet 31: 635-662
49. Shiloh Y (2003) ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer 3: 155-168
50. Spring K et al (2002) Mice heterozygous for mutation in Atm, the gene involved in ataxia-telangiectasia, have heightened susceptibility to cancer. Nat Genet 32: 185-190
51. Stankovi T, Stewart GS, Byrd P, Fegan C, Moss PA, Taylor AM (2002) ATM mutations in sporadic lymphoid tumours. Leuk Lymphoma 43: 1563-1571
52. Stewart GS et al (1999) The DNA double-strand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like disorder. Cell 99: 577-587
53. Stewart GS, Last JI, Stankovic T, Haites N, Kidd AM, Byrd PJ, Taylor AM (2001) Residual ataxia telangiectasia mutated protein function in cells from ataxia telangiectasia patients, with 5762ins 137 and 7271T→G mutations, showing a less severe phenotype. J Biol Chem 276: 30133-30141
54. Tavani F, Zimmerman RA, Berry GT, Sullivan K, Gatti R, Bingham P (2003) Ataxia-telangiectasia: the pattern of cerebellar atrophy on MRI. Neuroradiology 45: 315-319
55. Thorstenson YR et al (2003) Contributions of ATM mutations to familial breast and ovarian cancer. Cancer Res 63: 3325-3333
56. Uziel T, Lerenthal Y, Moyal L, Andegeko Y, Mittelman L, Shiloh Y (2003) Requirement of the MRN complex for ATM activation by DNA damage. EMBO J 22: 5612-5621
57. van den Bosch M, Bree RT, Lowndes NF (2003)The MRN complex: coordinating and mediating the response to broken chromosomes. EMBO Rep 4: 844-849
58. van Gent DC, Hoeijmakers JH, Kanaar R (2001) Chromosomal stability and the DNA double-stranded break connection. Nat Rev Genet 2: 196-206
59. Varon R et al (1998) Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome. Cell 93: 467-476